Malcolm MacEachern Symposium 2022

Biopharmaceutical Innovation After the Pandemic

Biopharmaceutical Innovation After the Pandemic

Each year, the Healthcare program at Kellogg convenes a group of healthcare experts for the MacEachern Symposium. This program includes two keynote lectures, one by a leading academic and a second by a leading industry practitioner. The symposium features distinguished speakers and business leaders from around the nation to discuss the most pressing issues in the healthcare industry.

Keynote Speaker
Scott Gottlieb, MD
Former FDA Commissioner

Malcolm MacEachern Memorial Lecturer
Pierre Azoulay, PhD
International Programs Professor of Management
MIT, Sloan School of Management

Panel Discussion: China as an Emerging Biotech Consumer and Supplier
Ricky Sun, PhD
Managing Director
Bain Capital Life Sciences
Patrik Ringblom
Vice President for Business Development in Rare Diseases, Novel Therapies and Alliances
The Janssen Pharmaceutical Companies of Johnson & Johnson

Lakeside Chat: Paying for New Innovations
Steve Miller, MD
Chief Clinical Officer
Cigna International
Moderator: Amanda Starc, PhD, Associate Professor of Strategy, Kellogg School of Management

May  12 and May 13, 2022


38th Annual MacEachern Symposium

Join students, faculty, and industry peers in discussion about Biopharmaceutical Innovation After the Pandemic.

May 12th
Alumni/Student Networking Event and Panel Discussion
5:30pm - 7:30pm
MATTER, 222 West Merchandise Mart Plaza, Suite 1230, Chicago, Illinois

May 13th
MacEachern Symposium
9:00am - 4:00pm
Kellogg School of Management, 2211 Campus Drive, Evanston, Illinois


For questions about the 2022 MacEachern Symposium:
Julie Gertz
Senior Program Development Manager/Healthcare at Kellogg


Featured Speakers

Pierre Azoulay, PhD

International PRogram professor of management, Mit, Sloan school of Management

Pierre Azoulay is the International Programs Professor of Management at the MIT Sloan School of Management, and a Research Associate at the National Bureau of Economic Research.
His current research focuses on empirical studies of the supply of biomedical innovators, particularly at the interface of academia and the biopharmaceutical industry. He also is interested in the topic of academic entrepreneurship, having recently concluded a major study of the antecedents and consequences of academic patenting. In the past, he has investigated the impact of superstar researchers on the research productivity of their colleagues, and the outsourcing strategies of pharmaceutical firms, in particular the role played by contract research organizations in the clinical trials process.
At MIT Sloan, he teaches courses on competitive strategy and innovation strategy to the EMBA students and Sloan Fellows, as well as a PhD class on the economics of ideas, innovation, and entrepreneurship.
He holds a Diplôme d’Études Supérieures de Gestion from the Institut National des Télécommunications, an MA from Michigan State University, and a PhD in management from MIT.

Scott Gottlieb, MD

Former FDA Commissioner

Scott Gottlieb, MD is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration from 2017 to 2019. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He is currently a senior fellow at the American Enterprise Institute and a member of the board of directors of Pfizer, Inc, Illumina Inc, and Tempus Labs. Dr. Gottlieb is a partner at the venture capital firm New Enterprise Associates where he is a member of the firm’s healthcare services and biopharma investment teams. For NEA, he serves on the boards of National Resilience and Aetion.

Under his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell based regenerative medicines, targeted drugs, and digital health devices. The agency advanced new models for the regulation of artificial intelligence devices, veterinary medicines, and orphan drugs; and implemented new reforms to standardize drug reviews and make important improvements in post market data collection and the use of realworld evidence. The agency’s historic and prolific advances in new policy distinguished his tenure as the FDA’s commissioner, in addition to a record-setting number of approvals of novel drugs, medical devices, and generic medicines in 2018 and again in 2019.

Dr. Gottlieb promoted policies to reduce death and disease from tobacco, improve food innovation and safety, expand the agency’s oversight of areas of emerging risk such as dietary supplements and cell-based medicine, and aggressively confront addiction crises. The FDA advanced new legislative frameworks to address the opioid crisis, grow its field operations, and modernize the regulation of diagnostic tests and over-the-counter drugs, among other initiatives. Dr. Gottlieb forged collaborative relations with Congress that saw FDA increase its total budget by about $1 billion over two years. During his tenure, he testified before Congress 20 times.

Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he helped implement the Medicare drug benefit, and advance policies to improve healthcare quality and promote the effective use of new medical technologies.

Dr. Gottlieb is author of the New York Times bestselling book “Uncontrolled Spread” and is widely published in leading medical journals and periodicals, including The Wall Street Journal, The New York Times, and The Washington Post. He holds an editorial position on the Journal of the American Medical Association. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019. Modern Healthcare has named Dr. Gottlieb as one of the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named Dr. Gottlieb as one of its “50 People Transforming Healthcare in 2018.” He is a contributor to CNBC and CBS News Face the Nation.

Dr. Gottlieb was a practicing hospitalist and a Clinical Assistant Professor at the New York University School of Medicine. He is an elected member of the National Academy of Medicine.

Steve Miller, MD

chief clinical officer, cigna international

Dr. Steve Miller, is a nationally recognized advocate for greater access, affordability and excellence in healthcare. He is a trusted expert and advisor for Cigna’s efforts across clinical policy, quality and performance programs. He stepped into this role in 2022 after serving as the company’s Chief Clinical Officer for nearly five years. 

He formerly served as Express Scripts’ Senior Vice President and Chief Medical Officer, responsible for supporting government relations, leading the Pharmacy & Therapeutics committee, managing the Medical Affairs team, leading Government Affairs and interfacing with client groups. During his 12 years in that position, Dr. Miller focused on improving health outcomes and value through e-prescribing initiatives, specialty solutions and overall product development. 

Dr. Miller’s expertise represents years as a medical researcher, clinician and administrator, and spans numerous healthcare subjects. He previously was the vice president and chief medical officer at Barnes-Jewish Hospital, Washington University School of Medicine in St. Louis. 

Dr. Miller received his medical degree from the University of Missouri-Kansas City. He trained in the Pathology and Research fellowship at the University of Alabama at Birmingham. He was the William J. and Dorothy Fish Kerr Fellow in Cardiology at the University of California, San Francisco. Dr. Miller also did Internal Medicine training at the University of Colorado and Nephrology and Transplantation at Washington University in St. Louis. He earned his MBA at the Olin School of Business at Washington University.

David Ernesto Munar

Ricky Sun, PhD

Managing Director, Bain CApital Life Sciences

Dr. Sun joined Bain Capital Life Sciences in 2016. He is a Managing Director. Prior to joining Bain Capital, from 2013 to 2016, he was a Director of Corporate Development and Strategy at Biogen. Prior to Biogen, Dr. Sun served as a Vice President at BlackRock, as a member of the Fundamental Equity division of BlackRock's Alpha Strategies Group and senior analyst for BlackRock's Fundamental Large Cap Growth equity team, covering the health care sector. Prior to that, he was a senior healthcare analyst at Citadel and Alyeska Investment Group in Chicago and worked as a pharmaceuticals equity research analyst on Wall Street, spending time at Lehman Brothers and Morgan Stanley. Dr. Sun began his career as a senior scientist at Ironwood Pharmaceutical where he was involved in the discovery and development of the drug Linzess for irritable bowel syndrome.

Dr. Sun received a PhD degree in Chemistry and Chemical Biology from Harvard University and was an NIH post-doctoral fellow in Biological Chemistry & Molecular Pharmacology at Harvard Medical School.  He also received an MBA from New York University Stern School of Business, where he was a Mildred Elperin Scholar.  He graduated summa cum laude from Berea College with a BA in chemistry.

mosaic bar


Getting Here & Parking

Major airlines fly into both O’Hare International Airport and Midway International Airport. O’Hare Airport is approximately 45 minutes from Kellogg and Midway Airport is approximately 60 minutes from Kellogg, but you may want to allow more time for traffic.

Taxi service from both airports can be arranged in advance of your visit for a reduced fare. Pre-arranged rides start at approximately $35 from O’Hare and $50 from Midway. For up-to-date fare information, please contact a taxi service directly. 
We are happy to provide a parking permit for visitors that drive to campus. Upon arriving, park at either the South Campus Parking Garage (1847 Campus Drive) or the North Campus Parking Garage (2311 North Campus Drive.) The North Campus Parking Garage is closer to the Global Hub. Before leaving campus make sure to ask the staff for a validated parking ticket to exit the garage.

Where to Stay

Airbnb has listings for rent throughout Evanston and Chicago

Hilton Garden Inn The Hilton
1818 Maple Ave., Evanston, IL 60201
Phone: 847.475.6400 or 1.877.STAYHGI

Hilton Orrington/Evanston
1710 Orrington Ave., Evanston, IL 60201
Phone: 888.677.4648

Holiday Inn Chicago: North-Evanston
1501 Sherman Ave., Evanston, IL 60201
Phone: 847.491.6400

Hyatt House Chicago/Evanston
1515 Chicago Ave., Evanston, IL 60201
Phone: 847.864.2300

Margarita European Inn
1566 Oak Ave., Evanston, IL 60201
Phone: 847.869.2273

North Shore Doubletree Hotel
9599 Skokie Blvd., Skokie, IL 60077
Phone: 847.679.7000

Stone Terrace Bed & Breakfast
1622 Forest Place, Evanston, IL 60201
Phone: 847.859.2198

Public Transportation

The Chicago Transit Authority (CTA) maintains an extensive system of elevated trains (also known as “the L”) and buses throughout Chicago and Evanston. The train stop closest to Kellogg is the Purple Line Foster stop on Church and Davis Streets. The 201 bus departs from the Howard St. terminal and stops on the corner of Foster and Sheridan.

Be advised, while inexpensive, taking the CTA from the airport can take up to 90 minutes and requires transferring trains.

MacEachern Previous Years


The Challenges of Paying for Valuable Pharmaceuticals
April 5, 2019

Keynote speaker:
John Milligan, PhD
Retired President and Chief Executive Officer
Gilead Sciences, Inc.

Malcolm MacEachern Memorial Lecturer:
Andrew Lo, PhD
Charles E. & Susan T. Harris Professor
MIT Sloan School of Management
Director of MIT's Laboratory for Financial Engineering and Principal Investigator,
MIT's Computer Science and Artificial Intelligence Laboratory

Lakeside Chat
John Prince
, '91, MBA
Chief Executive Officer

Craig Garthwaite, PhD
Associate Professor of Strategy, Herman Smith Professor in Hospital & Health Services Management,
Director, Healthcare at Kellogg
Northwestern University, Kellogg School of Management

Panel Discussion:
Amitabh Chandra, PhD
Henry & Allison McCance Professor of Business Administration,
Harvard Business School
Malcolm Wiener Professor of Social Policy, Director of Health Policy Research,
Harvard Kennedy School of Government, Harvard University

Arti Rai, JD
Elvin R. Latty Professor of Law, Co-Director, The Center for Innovation Policy
Duke University Law School


The Public-Private Partnership of U.S. Healthcare
April 27, 2018

Keynote speaker: Re-defining the Healthcare Experience...One Person at a Time 
Steve Nelson, MBA, MHSA
Office of the Chief Executive, UnitedHealth Group
Chief Executive Officer, UnitedHealthcare

Malcolm MacEachern Memorial Lecturer: The Role of Private Payers & Providers After the Affordable Care Act
Mark Duggan, PhD, MS
Wayne & Jodi Cooperman Professor of Economics and 
Trione Director Stanford Institute for Economics Policy Research
Stanford University

Discussion: Managing Public- Private Sector Partnerships in Healthcare
Craig Garthwaite
, PhD
Associate Professor of Strategy, Herman Smith Professor in Hospital & Health Services Management,
Director, Healthcare at Kellogg
Northwestern University, Kellogg School of Management

Christian Soura, MA
Vice President of Policy & Finance
South Carolina Hospital Association
Former Director
South Carolina Department of Health & Human Services


Can Markets Be Used to Control Healthcare Costs
May 18, 2017

Keynote speaker: How can Government and Markets work together to control Healthcare Cost 
Julian Harris, MD, MBA
CareAllies, A Cigna Company

Malcolm MacEachern Memorial Lecturer: The Affordable Care Act: Repeal and Replace? Or Rethink? New Models, Methods and Payments
James Weinstein, DO, MS
President & CEO
Dartmouth-Hitchcock Health

A Conversation on the Future of Anti-Trust in Healthcare Markets
Amanda Starc
, PhD
Associate Professor of Strategy
Northwestern University, Kellogg School of Management

David Dranove, PhD
Walter J. McNerney Professor of Health Industry Management, Professor of Strategy,
Faculty Director of PhD Program
Northwestern University, Kellogg School of Management


Public and Private Exchanges: What Does the Future Hold?
April 29, 2016

Keynote Speaker: Private Exchanges - Current and Future Perspectives
Ashok Subramanian, MA, MBA
Chief Executive Officer and Co-Founder

Malcolm MacEachern Memorial Lecturer: Public Health Insurance Exchanges: Where they came from and where are they going?
Jonathan Gruber, PhD
Ford Professor of Economics
Massachusetts Institute of Technology

Panel: Insights and Reactions from Insurers
Moderator: Leemore Dafny,
Professor of Strategy, Director of Health Enterprise Management 
Herman Smith Research Professor in Hospital and Health Services
Kellogg School of Management

Kevin Cassidy, MBA
Senior Vice President, Employer Group Sales & Client Management
Blue Cross Blue Shield of IL, MT, NM, OK, TX

Craig A. Hipp, CEBS
Vice President, Exchange Strategy/Strategic Initiatives
UnitedHealthcare National Accounts

Luncheon and the Year Ahead in Healthcare: A Forecasting Panel
Moderator: Andrew Ziskind, MD, MBA
Adjunct Professor of Health Enterprise Management
Kellogg School of Management
Managing Director, Clinical Solutions
Huron Healthcare

Edward F.X. Hughes, MD
Professor of Strategy
Kellogg School of Management

Mark Golberg
“Project X”, an innovative platform in the elder care space in development by Red Star Ventures

Robert York, MBA
Senior Vice President
Kaufman Hall

Ethan Arnold, MPH
Co-Founder & President
The Chartis Group


High-Priced Drugs: Problem or Progress?
May 8, 2015

Keynote speaker: Medicines and Pricing: Ensuring Accessibility, Affordability and Innovation
Justin McCarthy
Senior Vice President, Global Policy & International Public Affairs
Pfizer, Inc.

Malcolm MacEachern Memorial Lecturer: Paying for Innovation in Healthcare
Amitabh Chandra, PhD
Professor of Public Policy
Harvard University

Panel: Perspectives on Drug Pricing from Payers and Providers
Moderator: Leemore Dafny, 
Professor of Strategy, Director of Health Enterprise Management 
Herman Smith Research Professor in Hospital and Health Services
Kellogg School of Management

Peter Bach, MD
Memorial Sloan Kettering's Center for Health Policy and Outcomes

Steve B. Miller, MD
Senior Vice President & Chief Medical Officer
Express Scripts Inc.

Luncheon and the Year Ahead in Healthcare: A Forecasting Panel
Moderator: Craig Garthwaite, PhD
Assistant Professor of Strategy, Kellogg School of Management

Michael Sachs, MSPH

Andrew Ziskind, MD, MBA
Managing Director, Clinical Solutions
Huron Healthcare

Nicole Walker, MBA, MEM
Baird Capital